Kotani; Hidehito

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kotani; Hidehito.The latest application filed is for "predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor".

Company Profile

1.6.14

Kotani; Hidehito - Tsukuba N/A JP
Kotani; Hidehito - Ibaraki JP
KOTANI; HIDEHITO - Tsukuba-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination cancer therapy with an AKT inhibitor and other anticancer agents Grant 8,481,503 - Layton , et al. July 9, 2	2013-07-09
Predictive Biomarkers Useful For Cancer Therapy Mediated By A Wee1 Inhibitor App 20120157342 - Mizuarai; Shinji ; et al.	2012-06-21
Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents App 20110319354 - Layton; Mark E. ; et al.	2011-12-29
Utilization of histamine receptor h3 gene participating in body weight or food intake control Grant 7,767,881 - Kotani , et al. August 3, 2	2010-08-03
Method for evaluation of compound using RSK1 App 20100151050 - Mizuarai; Shinji ; et al.	2010-06-17
METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10 App 20100076059 - KOTANI; HIDEHITO ; et al.	2010-03-25
Method for Detecting p53 Dysfunction, Method for Molecular Diagnosis of Cancer and Method for Evaluating Compound Effective in Treating Cancer App 20090092971 - Mizuarai; Shinji ; et al.	2009-04-09
Method for examining obesity or leanness Grant 7,510,833 - Kotani , et al. March 31, 2	2009-03-31
Method Of Assuming Drug Sensitivity To Cdk4 Inhibitor App 20090081645 - Kotani; Hidehito ; et al.	2009-03-26
Method of evaluating compound efficacious in treating obesity Grant 7,491,381 - Kotani , et al. February 17, 2	2009-02-17
Method For Predicting A Drug Transport Capability By Abcg2 Polymorphisms App 20080182267 - KOTANI; Hidehito ; et al.	2008-07-31
Constitutively active histamine H3 receptor mutants and uses thereof Grant 7,279,293 - Kotani , et al. October 9, 2	2007-10-09
Drug Resistance-associated Gene And Use Thereof App 20070141619 - KOMATANI; Hideya ; et al.	2007-06-21
Method For Examining Obesity Or Leanness App 20070031833 - Kotani; Hidehito ; et al.	2007-02-08
Method of evaluating compound efficacious in treating obesity by using slc25a10 App 20060198788 - Kotani; Hidehito ; et al.	2006-09-07
Method of evaluating compound efficacious in treating obesity App 20060148739 - Kotani; Hidehito ; et al.	2006-07-06
Histamine receptor h3 ordinary activity mutant and utilization thereof App 20050234223 - Kotani, Hidehito ; et al.	2005-10-20
Utilization of histamine receptor h3 gene participating in body weight or food intake control App 20040259778 - Kotani, Hidehito ; et al.	2004-12-23
Drug resistance-associated gene and use thereof App 20030232362 - Komatani, Hideya ; et al.	2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.